Cegedim: Consolidated Turnover as at 31 March 2004.

Business Editors/Health/Medical Writers

PARIS--(BUSINESS WIRE)--May 10, 2004

CEGEDIM (CGDM.PA)

               Consolidated Turnover as at 31 March 2004

----------------------------------------------------------------------
                            31 March    31 March             Organic
GROUP CEGEDIM                 2004       2003                 growth
                            EUR '000   EUR '000    Growth      (a)
-------------------------- ---------- ----------  --------  ----------
Health and strategic data    85,545     72,981     17.2 %     12.6 %
  Customer relationship
   management and
   strategic data            45,357     40,806       11 %       11 %
  Healthcare professionals   22,694     19,577       16 %       16 %
  Electronic money,
   insurance and
   cash flows in the
   healthcare sector         17,494     12,598       39 %       12 %
Technologies and services    16,174     16,006        1 %        1 %
  Technologies                7,842      7,141       10 %       10 %
  Services                    8,332      8,865      - 6 %      - 6 %

-------------------------- ---------- ----------  --------  ----------
 Total                      101,719     88,987     14.3 %     10.5 %
========================== ========== ==========  ========  ==========
   (a) Organic growth:
        All acquisitions completed after 31 March 2003 are excluded
        from 2004 turnover, and
        All businesses' disposals completed after 31 March 2003 are
        excluded from 2004 turnover.


                             Cegedim Group

    First quarter turnover up 14.3 %.

    This does not yet include the impact of the acquisition of Pharma
Marketing, the Scandinavian leader in pharmaceutical CRM (to be
consolidated from April 1st, 2004).
    In the core business of "CRM and strategic data" for the
pharmaceutical companies Cegedim achieved dynamic growth. In line with
forecasts, international operations grew significantly (+ 24 %) while
French operations achieved a satisfying growth rate of 4 %.
    There was notable growth in the computerization of "Healthcare
professionals." This is an extraordinary event in the United-Kingdom
market, as a consequence of the last uninhibited spending plans of the
Primary Care Trusts, before the new healthcare market organization is
launched. In Practice Systems thus achieved a 22 % growth in the first
quarter. However, this will have a limited positive impact on this
sector's margin, as this growth mainly relies on exceptional sales of
hardware to doctors.
    "Electronic money, insurance and cash flows" operations in the
healthcare sector now include the Proval group and also benefit from
the recurring revenue generated by Soltim with the start of new
clients at the end of 2003, which provides a favorable comparison with
the first quarter 2003.
    The "Technologies" sector should perform well throughout the year
2004.
    "Services" especially in the direct marketing business are still
facing a difficult market.

                             2004 Outlook

    This very good first quarter and the integration of Pharma
Marketing from April 1st, 2004 allows Cegedim's management to be
confident of achieving without difficulty the year-end objective of a
8 % growth in turnover and to surpass the 15 % EBIT growth forecast.